Alkeon Capital Management LLC Neoleukin Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.72 - $5.23 $386,905 - $1.18 Million	-224,945 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $1.28 Million - $2.13 Million	-275,055 Reduced 55.01%	224,945 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$10.17 - $14.56 $3.05 Million - $4.37 Million	300,000 Added 150.0%	500,000 $7.05 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $530,000 - $2.54 Million	200,000 New	200,000 $2.46 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.